Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
Healthcare
$18.98 -0.05%
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
52W Low $15.35High $20.30
Volume 0.37M
Average 0.43M
ODTX Common Stock Repurchased
Cash spent buying back the company's own shares.
No reported Common Stock Repurchased figures are available to summarize.
Common Stock Repurchased history
Currency unavailable · from the cash flow
No Common Stock Repurchased data reported for this period type.
Common Stock Repurchased vs competitors
How ODTX compares with its peers on the latest reported figures
ODTX Competitors
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $64.2M USD | +1215.6% | — | 27.6% | |
| LTM Mar 2026 | $123K USD | — | — | — | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $17K USD | +200.0% | — | 0.2% |
| LTM Mar 2026 | $9K USD | -96.9% | — | 0.1% | |
| LTM Sep 2026 | $0 USD | +100.0% | — | 0.0% | |
| LTM Jun 2026 | $0 USD | — | — | 0.0% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $0 USD | — | — | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +150.0% | — | 0.1% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Currency unavailable
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.